A collaborative study between three founding members of the Great Lakes Breast Cancer Consortium – UPMC, Cleveland Clinic, and The James – identified meaningful differences in clinicopathological features between ILC and IDC/NST, analyzing data from more than 30,000 breast cancer patients. For patients with ILC we noted more lymph node involvement, diagnoses at later stage, higher grade and larger size tumors (with an increase over time), more mastectomies, and worse outcome – despite fewer cases with high recurrence scores.
Important ILC Research: “Clinicopathological Features and Outcomes Comparing Patients With Invasive Ductal and Lobular Breast Cancer”
